PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdel
Status:
Unknown status
Trial end date:
2018-11-23
Target enrollment:
Participant gender:
Summary
The hospital pharmacy at the Zuyderland Medical Centre developed the DElirium MOdel (DEMO) to
predict which patients are at risk of developing a delirium in patients aged 60 or older.
With this delirium risk prediction model we aim to predict more accurately which patients are
at high risk of developing a delirium and want to investigate if these patients can benefit
from prophylactic haloperidol.